Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-17-254426
Filing Date
2017-08-10
Accepted
2017-08-10 16:02:04
Documents
64
Period of Report
2017-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d425841d10q.htm 10-Q 837721
2 EX-31.1 d425841dex311.htm EX-31.1 8315
3 EX-31.2 d425841dex312.htm EX-31.2 8314
4 EX-32.1 d425841dex321.htm EX-32.1 3919
5 EX-32.2 d425841dex322.htm EX-32.2 3922
  Complete submission text file 0001193125-17-254426.txt   4505316

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT alrn-20170630.xml EX-101.INS 822838
7 XBRL TAXONOMY EXTENSION SCHEMA alrn-20170630.xsd EX-101.SCH 44522
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE alrn-20170630_cal.xml EX-101.CAL 48446
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE alrn-20170630_def.xml EX-101.DEF 189174
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE alrn-20170630_lab.xml EX-101.LAB 368321
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE alrn-20170630_pre.xml EX-101.PRE 294745
Mailing Address 281 ALBANY STREET CAMBRIDGE MA 02139
Business Address 281 ALBANY STREET CAMBRIDGE MA 02139 617-995-0900
AILERON THERAPEUTICS INC (Filer) CIK: 0001420565 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38130 | Film No.: 171021440
SIC: 2834 Pharmaceutical Preparations